PacBio announces positive study results for HiFi long-read sequencing technology in identifying genetic causes of rare diseases.

PacBio reports dismal preliminary fourth-quarter 2024 results, caused by lower instrument. New launches and clinical focus set the stage for market...

PacBio reports dismal preliminary fourth-quarter 2024 results, caused by lower instrument. New launches and clinical focus set the stage for market...

PACB continues to deliver growth from its unique technologies amid business seasonality concerns.

The technology of QRGenetics identifies the activity of defective proteins in children with ultra-rare disease with no cure, and seeks out existing...

According to a new study in Science, large-scale changes in the genome inherited from parents are significant risk factors for pediatric solid...

Ascletis Pharma Inc., an innovative R&D driven biotech, announces today positive topline results from its US single ascending dose (SAD) study...

MINNEAPOLIS, MN -- January 22, 2025 -- Humanetics Corporation (Humanetics) announced today the results of its Phase 2 clinical trial of BIO 300 Oral...

MongoDB's innovation, strategic investments and expanding client base position it for long-term growth despite the recent stock dip.